Article Details

Promising Outlook for Olema Pharmaceuticals' OP-2313 as KAT6 Inhibitor Shows Efficacy in ...

Retrieved on: 2024-06-04 19:40:10

Tags for this article:

Click the tags to see associated articles and topics

Promising Outlook for Olema Pharmaceuticals' OP-2313 as KAT6 Inhibitor Shows Efficacy in .... View article details on hiswai:

Excerpt

... Pfizer's KAT6 inhibitor, PF-07248144. Bodnar's assessment is influenced by the promising interim efficacy data from Pfizer's monotherapy in a ...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up